Results
1 -
8 of
8
(Click
here to explore results)
- Progress in mechanistically novel treatments for schizophrenia. James Neef, Daniel S. Palacios
, RSC Med. Chem.
, 2021
, 12
, 1459
- M1 muscarinic cetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease. Michael Decker, Ulrike Holzgrabe
, Med. Chem. Commun.
, 2012
, 3
, 752
- Designing drugs and chemical probes with the dualsteric approach. Jinyin Zha, Jixiao He, Chengwei Wu, Mingyang Zhang, Xinyi Liu, Jian Zhang
, Chem. Soc. Rev.
, 2023
, 52
, 8651
- Review on anti-alzheimer drug development: approaches, challenges and perspectives. Abdallah E. Abdallah
, RSC Adv.
, 2024
, 14
, 11057
- Two decades of new drug discovery and development for Alzheimer's disease. Zhidong Liu, Aihua Zhang, Hui Sun, Ying Han, Ling Kong, Xijun Wang
, RSC Adv.
, 2017
, 7
, 6046
- Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders. Gregory J. Digby, Jana K. Shirey, P. Jeffrey Conn
, Mol. BioSyst.
, 2010
, 6
, 1345
- The in silico and in vivo evaluation of puerarin against Alzheimer's disease. Song Liu, Xiao-Lu Cao, Guang-Qi Liu, Tong Zhou, Xi-Liang Yang, Bing-Xin Ma
, Food Funct.
, 2019
, 10
, 799
- Analysing the effect caused by increasing the molecular volume in M1-AChR receptor agonists and antagonists: a structural and computational study. Wilber Montejo-López, Raúl Sampieri-Cabrera, María Inés Nicolás-Vázquez, Juan Manuel Aceves-Hernández, Rodrigo Said Razo-Hernández
, RSC Adv.
, 2024
, 14
, 8615